Computational analysis of the divergent neurotranscriptomic signatures of major depression and suicidality
Authors:
Open Access
- 27 July 2024
- journal article
- research article
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 25 (1)
Abstract
Background: Suicide is a leading cause of death globally. Identifying individuals at higher suicidal risk is a key to suicide prevention. Patients with comorbid psychiatric disorders, especially major depressive disorder (MDD), are known to be highly prone to suicidality. However, the behavioural manifestations of MDD and suicidality are distinct, indicating potentially unique molecular underpinnings, of which our current understanding is limited. Delineating the unique and shared molecular etiologies of MDD and suicidality would be imperative to devise effective treatment strategies for suicidal behaviour. To this end, we analysed the existing literature pertaining to transcriptomic alterations in brain samples of individuals who died from MDD or by suicide. Subsequently, biological processes associated with the differentially expressed genes (DEGs) were identified. In addition, we also examined the transcriptional regulators (TRs) potentially driving cortical gene expression changes in MDD and suicidality. Results: A set of immunological genes was found to be commonly upregulated in MDD but downregulated in suicide. Actin and cytoskeleton organization genes also had a similar trend. In addition, MDD-upregulated and suicide-downregulated genes were found to have overrepresented target sites for 40 TRs associated with epigenetic as well as polymerase-mediated regulation. Any variations in the levels of these TRs could be of behavioural consequence in MDD and suicidality. Conclusions: A clear understanding of the condition-specific neurotranscriptomic differences in MDD and suicidality would be valuable in order to delineate the biological mechanisms underlying these conditions. Importantly, it would provide insights into more effective treatment strategies for suicidality among individuals with or without MDD. However, we have yet to determine the molecular basis of suicidality in the context of MDD and as a standalone mental condition. In this regard, the present findings would be of scientific and clinical relevance and could stimulate further research.Keywords
Funding Information
- Department of Science and Technology, Govt. of India (SRG/2019/000382)
This publication has 33 references indexed in Scilit:
- Biallelic loss-of-function variants in CACHD1 cause a novel neurodevelopmental syndrome with facial dysmorphism and multisystem congenital abnormalitiesGenetics in Medicine, 2023
- Suicide, neuroinflammation and other physiological alterationsEuropean Archives of Psychiatry and Clinical Neuroscience, 2023
- Psychoneuroimmunology: The new frontier in suicide researchBrain, Behavior, & Immunity - Health, 2021
- A meta-study on transcription factor networks in the suicidal brainJournal of Psychiatric Research, 2021
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- Transcription Factor Motifs Associated with Anterior Insula Gene Expression Underlying Mood Disorder PhenotypesMolecular Neurobiology, 2021
- The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer’s Disease and Other Neurodegenerative DisordersNeurochemical Research, 2020
- Microtubule and microtubule associated protein anomalies in psychiatric diseaseCytoskeleton, 2016
- A pilot integrative genomics study of GABA and glutamate neurotransmitter systems in suicide, suicidal behavior, and major depressive disorderAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2016
- A breach in the scaffold: The possible role of cytoskeleton dysfunction in the pathogenesis of major depressionAgeing Research Reviews, 2013